[1]
O. M. Hassan, A. A. R. Mahmood, and L. Tahtamouni, “Synthesis and docking studies of new 5-bromoindole-2-carboxylic acid oxadiazole derivatives as EGFR inhibitors”, Tikrit J. Pharm. Sci., vol. 17, no. 1, pp. 58–77, Jun. 2023.